BARCLAYS PLC - CUE BIOPHARMA INC ownership

CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 64 filers reported holding CUE BIOPHARMA INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of CUE BIOPHARMA INC
ValueSharesWeighting
Q3 2023$28
-41.7%
12,013
-7.2%
0.00%
Q2 2023$48
+118.2%
12,946
+114.7%
0.00%
Q1 2023$22
+29.4%
6,0290.0%0.00%
Q4 2022$17
-99.9%
6,029
-2.6%
0.00%
Q3 2022$14,000
-22.2%
6,188
-14.2%
0.00%
Q2 2022$18,000
-70.0%
7,214
-40.9%
0.00%
Q1 2022$60,000
-94.0%
12,211
-86.3%
0.00%
Q4 2021$1,006,000
+249.3%
88,842
+349.0%
0.00%
Q3 2021$288,000
+336.4%
19,785
+251.3%
0.00%
Q2 2021$66,000
-78.1%
5,632
-77.2%
0.00%
Q1 2021$302,000
+81.9%
24,730
+85.4%
0.00%
Q4 2020$166,000
-42.0%
13,342
-29.9%
0.00%
Q3 2020$286,000
-24.9%
19,028
+22.4%
0.00%
Q2 2020$381,000
+305.3%
15,547
+133.0%
0.00%
Q1 2020$94,000
-70.3%
6,672
-66.6%
0.00%
Q4 2019$317,000
+164.2%
19,957
+40.2%
0.00%
Q3 2019$120,000
+14.3%
14,235
+22.4%
0.00%
Q2 2019$105,000
+162.5%
11,632
+126.5%
0.00%
Q1 2019$40,000
-33.3%
5,136
-22.5%
0.00%
Q3 2018$60,000
+300.0%
6,628
+412.2%
0.00%
Q2 2018$15,000
-42.3%
1,294
-29.8%
0.00%
Q1 2018$26,0001,8430.00%
Other shareholders
CUE BIOPHARMA INC shareholders Q4 2019
NameSharesValueWeighting ↓
Prosight Management, LP 829,042$9,376,0005.61%
P.A.W. CAPITAL CORP 120,000$1,357,0001.24%
Nantahala Capital Management 2,539,700$28,724,0001.01%
Slate Path Capital LP 1,483,619$16,780,0000.88%
SANDERS MORRIS HARRIS LLC 359,113$4,416,0000.76%
APOGEM CAPITAL LLC 62,295$705,0000.46%
Robertson Stephens Wealth Management, LLC 478,500$5,411,0000.46%
Bleichroeder LP 200,000$2,262,0000.35%
ADVISORY RESEARCH INC 257,225$2,909,0000.23%
Granite Point Capital Management, L.P. 110,000$1,244,0000.21%
View complete list of CUE BIOPHARMA INC shareholders